Brief: Axovant Announces Positive Data On Axo-Lenti-Pd

Sio Gene Therapies

13/01/2020 12:01

Jan 13 (Reuters) - Axovant Gene Therapies Ltd  AXGT.O :
    * AXOVANT ANNOUNCES POSITIVE 12-MONTH DATA ON AXO-LENTI-PD
AND 
PROVIDES UPDATES ACROSS GENE THERAPY PIPELINE PROGRAMS
    * AXOVANT GENE THERAPIES - AXO-LENTI-PD WAS OBSERVED TO BE
WELL-TOLERATED WITH NO SERIOUS ADVERSE EVENTS ATTRIBUTABLE TO
GENE THERAPY
    * AXOVANT GENE THERAPIES LTD - EXPECTS TO INITIATE
RANDOMIZED,
SHAM-CONTROLLED PART OF SUNRISE-PD PHASE 2 STUDY BY END OF 2020

Source text for Eikon:  ID:nGNXbJSHd5 
Further company coverage:  AXGT.O 

 ((Reuters.Briefs@thomsonreuters.com;))